EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents


Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents



Journal of Dermatological Treatment 2020: 1-5



ISSN/ISBN: 0954-6634

PMID: 33143506

DOI: 10.1080/09546634.2020.1837721

Until recently, treatment of atopic dermatitis has been limited to topical corticosteroids, calcineurin inhibitors, phototherapy, and systemic immunomodulatory agents. With improved understanding of the pathogenesis underlying atopic dermatitis, targeted oral small molecules and topical agents are being developed. Discuss efficacy and safety profiles of emerging oral small molecules and targeted topical agents in phase 2 and 3 clinical trials. A systemic literature review was conducted to identify results of randomized, placebo-controlled trials of oral small molecules and topical Janus kinase inhibitors up to March 1 2020 for the treatment of atopic dermatitis. Three novel oral small molecules, abrocitinib, upadacitinib, and baricitinib, demonstrated improvement of clinical severity, pruritus, and quality of life with acceptable safety profiles. Apremilast, a phosphodiesterase inhibitor, was less efficacious with use limited by adverse effects. Two novel topical agents, ruxolitinib and delgocitinib, were effective and well-tolerated. Targeted therapeutics including oral small molecules and topical agents show promise for the treatment of atopic dermatitis. The use of validated core measures is necessary for future trials in order to adequately compare agents and progress evidence-based medicine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 071692857

Download citation: RISBibTeXText

Related references

New and emerging targeted systemic therapies: a new era for atopic dermatitis. Journal of Dermatological Treatment 29(4): 364-374, 2018

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis. Dermatology and Therapy 12(5): 1181-1196, 2022

Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients. Journal of Allergy and Clinical Immunology. in Practice 9(4): 1449-1460, 2021

New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis. Journal of Clinical and Aesthetic Dermatology 12(12): 28-34, 2019

Current and emerging topical therapies for atopic dermatitis. Clinics in Dermatology 35(4): 375-382, 2017

Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology 233(5): 333-343, 2017

Novel topical and systemic therapies in atopic dermatitis. Immunological Medicine 42(2): 84-93, 2019

Emerging systemic therapies for atopic dermatitis: biologics. Journal of Dermatological Treatment 2020: 1-5, 2020

Emerging Treatment Options in Atopic Dermatitis: Systemic Therapies. Dermatology 233(5): 344-357, 2017

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis. Children 6(11), 2019

Current and emerging biologic and small molecule therapies for atopic dermatitis. Expert Opinion on Biological Therapy 19(4): 367-380, 2019

Comparison of treatment standards in Atopic Dermatitis management across selected geographies prior to emerging targeted therapies onset. Journal of Drug Assessment 8(1): 122-125, 2019

Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors. Allergology International: Official Journal of the Japanese Society of Allergology 71(1): 40-46, 2022

Oral small molecules for the treatment of atopic dermatitis: a systematic review. Journal of Dermatological Treatment 30(6): 550-557, 2019

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology 71(1): 116-132, 2014